135 related articles for article (PubMed ID: 9756413)
41. Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells.
Cardoso AA; Seamon MJ; Afonso HM; Ghia P; Boussiotis VA; Freeman GJ; Gribben JG; Sallan SE; Nadler LM
Blood; 1997 Jul; 90(2):549-61. PubMed ID: 9226154
[TBL] [Abstract][Full Text] [Related]
42. Importance of TNF production for the curative effectiveness of low dose melphalan therapy for mice bearing a large MOPC-315 tumor.
Gorelik L; Rubin M; Prokhorova A; Mokyr MB
J Immunol; 1995 Apr; 154(8):3941-51. PubMed ID: 7706732
[TBL] [Abstract][Full Text] [Related]
43. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity.
Van Gool SW; de Boer M; Ceuppens JL
J Immunol; 1993 Apr; 150(8 Pt 1):3254-63. PubMed ID: 7682237
[TBL] [Abstract][Full Text] [Related]
44. Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation.
Thebeau LG; Morrison LA
J Virol; 2003 Feb; 77(4):2426-35. PubMed ID: 12551980
[TBL] [Abstract][Full Text] [Related]
45. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.
Bai XF; Liu J; May KF; Guo Y; Zheng P; Liu Y
Blood; 2002 Apr; 99(8):2880-9. PubMed ID: 11929778
[TBL] [Abstract][Full Text] [Related]
46. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.
Yang Y; Wilson JM
Science; 1996 Sep; 273(5283):1862-4. PubMed ID: 8791591
[TBL] [Abstract][Full Text] [Related]
47. T lymphocyte and monocyte interaction by CD40/CD40 ligand facilitates a lymphoproliferative response and killing of Cryptococcus neoformans in vitro.
Vecchiarelli A; Retini C; Pietrella D; Monari C; Kozel TR
Eur J Immunol; 2000 May; 30(5):1385-93. PubMed ID: 10820385
[TBL] [Abstract][Full Text] [Related]
48. CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation.
Zhan Y; Corbett AJ; Brady JL; Sutherland RM; Lew AM
J Immunol; 2000 Oct; 165(7):3612-9. PubMed ID: 11034363
[TBL] [Abstract][Full Text] [Related]
49. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
[TBL] [Abstract][Full Text] [Related]
50. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
51. CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells.
Hu HM; Winter H; Ma J; Croft M; Urba WJ; Fox BA
J Immunol; 2002 Nov; 169(9):4897-904. PubMed ID: 12391201
[TBL] [Abstract][Full Text] [Related]
52. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
Hancock WW; Sayegh MH; Zheng XG; Peach R; Linsley PS; Turka LA
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13967-72. PubMed ID: 8943044
[TBL] [Abstract][Full Text] [Related]
53. Expression and functional role of co-stimulatory molecules in CD40+IL-4-stimulated B cells from atopic and non-atopic donors.
Oberwalleney G; Henz BM; Worm M
Acta Derm Venereol; 2000; 80(4):287-91. PubMed ID: 11028864
[TBL] [Abstract][Full Text] [Related]
54. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.
Kennedy MK; Picha KS; Fanslow WC; Grabstein KH; Alderson MR; Clifford KN; Chin WA; Mohler KM
Eur J Immunol; 1996 Feb; 26(2):370-8. PubMed ID: 8617306
[TBL] [Abstract][Full Text] [Related]
55. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.
Yellin MJ; Brett J; Baum D; Matsushima A; Szabolcs M; Stern D; Chess L
J Exp Med; 1995 Dec; 182(6):1857-64. PubMed ID: 7500031
[TBL] [Abstract][Full Text] [Related]
56. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.
Borrow P; Tishon A; Lee S; Xu J; Grewal IS; Oldstone MB; Flavell RA
J Exp Med; 1996 May; 183(5):2129-42. PubMed ID: 8642323
[TBL] [Abstract][Full Text] [Related]
57. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
58. Modulation of costimulation to enhance tumor immunity.
Vesosky B; Hurwitz AA
Cancer Immunol Immunother; 2003 Nov; 52(11):663-9. PubMed ID: 12920481
[No Abstract] [Full Text] [Related]
59. Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma.
Cook-Mills JM; Mokyr MB; Cohen RL; Perlman RL; Chambers DA
Cancer Immunol Immunother; 1995 Feb; 40(2):79-87. PubMed ID: 7882386
[TBL] [Abstract][Full Text] [Related]
60. Low-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon gamma in the therapeutic outcome.
Gorelik L; Mokyr MB
Cancer Immunol Immunother; 1995 Dec; 41(6):363-74. PubMed ID: 8635194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
